Considering previous research on the use of deflamin to inhibit MMP-9 in other animal models of disease [30,31,32,33], we investigated for the first time the biological effect of deflamin in a murine COPD model as a novel approach to explore its therapeutic potential in this disease. The gene discussed is MMP9; the disease is chronic obstructive pulmonary disease.